ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
about
Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.Invasive fungal infections: managing the continuum of risk in HCT patients.FungiScope™ -Global Emerging Fungal Infection Registry.Drug development challenges and strategies to address emerging and resistant fungal pathogens.Combination therapy for the treatment of pulmonary mold infections.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children.Pharmacodynamics of the Long Acting Echinocandin, CD101, in the Neutropenic Invasive Candidiasis Murine Model Using an Extended Interval Dosing Design.Rare fungal infectious agents: a lurking enemy.Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A. nidulans.Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient.How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.Recent advances in the understanding and management of mucormycosisDeferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case seriesTreatment of cerebral mucormycosis with drug therapy alone: A case reportTreatment of AspergillosisPrimary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell TransplantationManagement of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations
P2860
Q36396166-307BDE19-A402-4EEB-935A-84136B7B228FQ38661492-EAB02D7F-61D4-45A5-A3B6-113CC4D50FC0Q38668606-3448EBE0-4B1C-49A9-89A7-768A08090FA9Q38798805-83CA792C-9195-43C7-A493-04C3C875F92EQ38806932-1D3C8914-6AB0-47AC-BE5E-83984562E420Q39196802-85F190BA-2D0D-4F95-B5E5-DC60108B723FQ40043040-CBAFCFDB-AFB6-4D70-B8CF-D135DA863295Q40045642-CB83A28B-109B-4522-A6D8-82AD1CD3B6A7Q40094752-B9CDD384-EFF5-4CDE-A398-F46C68401B4CQ46248423-228BAD38-BE1B-451D-AD96-1CE40E360356Q46258749-1D82A059-1BAC-4C3D-BC1C-64D673570E85Q46263165-28E3A66A-225F-4A6D-94A9-0F6235F5E1ABQ46362200-D84AAE77-9E47-4B11-8392-01D1B2CBB20FQ47133461-1394C13D-577D-4576-91EA-D74E6A84C8ADQ48118247-A73C1503-177C-4CD9-A082-C7E7503D0D98Q48179374-1D1A5742-7BED-4DFB-88BF-728316761313Q52728829-C8C7F548-CD7F-4DD6-BD9D-78FEBFBABB9EQ54214603-5B7C8E90-088B-43AD-971C-FC7702FC2166Q54957028-7482FAB4-71A5-4407-BF81-BB8E8E4A9132Q55479804-3DBFDAA7-9D6F-4030-AE74-2A67E8C71099Q57116582-A145A598-7855-4CE5-848C-4E6C8F454555Q57821495-D4AAB944-8801-4887-B64F-8610DEE48A7CQ58697627-C35DBF71-7682-4C80-9118-36216D34BA54Q58765898-0ED8E707-F7E1-4AE5-8EB0-C526E40C3419Q58772822-9CA115C8-7034-426C-A50A-C0090D400E99Q58791971-C28621A8-4E00-4B44-8D6B-E271E6D0573F
P2860
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@ast
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@en
ECIL-6 guidelines for the trea ...... stem cell transplant patients.
@nl
type
label
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@ast
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@en
ECIL-6 guidelines for the trea ...... stem cell transplant patients.
@nl
prefLabel
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@ast
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@en
ECIL-6 guidelines for the trea ...... stem cell transplant patients.
@nl
P2093
P2860
P50
P921
P1433
P1476
ECIL-6 guidelines for the trea ...... stem cell transplant patients
@en
P2093
Andreas H Groll
Anna Skiada
Claudio Viscoli
Frederic Tissot
Georgios Petrikkos
Livio Pagano
Samir Agrawal
P2860
P304
P356
10.3324/HAEMATOL.2016.152900
P577
2016-12-23T00:00:00Z